Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07044388

Coping With Asthma Throughout Life Management Program

Coping With Asthma Throughout Life Management: CALM Program for African American Adult Patients With Asthma

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
Duke University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine if the Coping with Asthma through Life Management (CALM) intervention, designed to help Black adult with asthma cope with stress, is feasible and acceptable.

Detailed description

Asthma medication nonadherence is a major contributor to asthma morbidity and mortality in Black adults. Black adults with asthma reported that increased psychosocial stress (e.g., perceived discrimination, job stress, caregiver burden), health-related stress (e.g., concern about asthma control), and economic stress (e.g., economic strain) were barriers to asthma medication adherence and control. The study's hypothesis is that CALM, targeting multiple stressors specifically faced by Black adults with asthma, will be feasibly implemented in a health system, will be acceptable to program participants, and will be a potentially effective intervention to improve asthma medication adherence and asthma control.

Conditions

Interventions

TypeNameDescription
BEHAVIORALCoping with asthma through life management programParticipants will complete surveys, learn stress coping strategies, receive asthma education information, and obtain access local community financial resources.
BEHAVIORALWaitlist Control (CALM)Participants in this group will complete surveys but will not receive the CALM intervention. Upon completing the study after 12 weeks they will be able to complete the program if they would like the resources/materials to learn healthy stress coping strategies, asthma health education, and access to financial resources.

Timeline

Start date
2026-06-15
Primary completion
2026-07-30
Completion
2026-09-30
First posted
2025-07-01
Last updated
2026-03-20

Source: ClinicalTrials.gov record NCT07044388. Inclusion in this directory is not an endorsement.